Cabio Biotech (Wuhan) Co., Ltd.

SHSE:688089 Stock Report

Market Cap: CN¥4.5b

Cabio Biotech (Wuhan) Valuation

Is 688089 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 688089 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 688089 (CN¥26.85) is trading above our estimate of fair value (CN¥2.14)

Significantly Below Fair Value: 688089 is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 688089?

Other financial metrics that can be useful for relative valuation.

688089 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue8.7x
Enterprise Value/EBITDA27.4x
PEG Ratio1.8x

Price to Earnings Ratio vs Peers

How does 688089's PE Ratio compare to its peers?

The above table shows the PE ratio for 688089 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average41.4x
300239 Baotou Dongbao Bio-TechLtd
36.7xn/aCN¥3.3b
688267 China Catalyst Holding
27.9x20.2%CN¥4.1b
688179 Shanghai Aladdin Biochemical TechnologyLtd
43.5xn/aCN¥4.5b
002054 Dymatic ChemicalsInc
57.6xn/aCN¥2.7b
688089 Cabio Biotech (Wuhan)
39.3x22.4%CN¥4.5b

Price-To-Earnings vs Peers: 688089 is good value based on its Price-To-Earnings Ratio (39.3x) compared to the peer average (41.4x).


Price to Earnings Ratio vs Industry

How does 688089's PE Ratio compare vs other companies in the CN Chemicals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a39.4%
n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a39.4%
n/an/an/a
No more companies

Price-To-Earnings vs Industry: 688089 is expensive based on its Price-To-Earnings Ratio (39.3x) compared to the CN Chemicals industry average (37.4x).


Price to Earnings Ratio vs Fair Ratio

What is 688089's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

688089 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio39.3x
Fair PE Ratio22.9x

Price-To-Earnings vs Fair Ratio: 688089 is expensive based on its Price-To-Earnings Ratio (39.3x) compared to the estimated Fair Price-To-Earnings Ratio (22.9x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 688089 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCN¥26.85
CN¥18.50
-31.1%
8.1%CN¥20.00CN¥17.00n/a2
Nov ’25CN¥20.92
CN¥18.50
-11.6%
8.1%CN¥20.00CN¥17.00n/a2
Oct ’25CN¥20.29
CN¥18.50
-8.8%
8.1%CN¥20.00CN¥17.00n/a2
Sep ’25CN¥15.54
CN¥18.50
+19.0%
8.1%CN¥20.00CN¥17.00n/a2
Aug ’25CN¥15.52
CN¥18.50
+19.2%
8.1%CN¥20.00CN¥17.00n/a2
Jul ’25CN¥13.30
CN¥18.50
+39.1%
8.1%CN¥20.00CN¥17.00n/a2
Jun ’25CN¥15.58
CN¥18.50
+18.7%
8.1%CN¥20.00CN¥17.00n/a2
May ’25CN¥19.65
CN¥18.50
-5.9%
8.1%CN¥20.00CN¥17.00n/a2
Oct ’24CN¥19.57
CN¥36.43
+86.1%
17.6%CN¥42.86CN¥30.00CN¥20.292
Sep ’24CN¥21.03
CN¥36.43
+73.2%
17.6%CN¥42.86CN¥30.00CN¥15.542
Aug ’24CN¥22.05
CN¥35.71
+62.0%
20.0%CN¥42.86CN¥28.57CN¥15.522
Jul ’24CN¥21.29
CN¥35.71
+67.8%
20.0%CN¥42.86CN¥28.57CN¥13.302
Jun ’24CN¥20.33
CN¥35.71
+75.7%
20.0%CN¥42.86CN¥28.57CN¥15.582
May ’24CN¥22.97
CN¥35.71
+55.5%
20.0%CN¥42.86CN¥28.57CN¥19.652
Apr ’24CN¥27.94
CN¥40.36
+44.4%
6.2%CN¥42.86CN¥37.86CN¥15.092
Mar ’24CN¥36.05
CN¥40.36
+11.9%
6.2%CN¥42.86CN¥37.86CN¥13.332

Analyst Forecast: Target price is lower than the current share price.


Discover undervalued companies